ChiCTR2100048830
结束
/
/
/
2021-07-18
/
/
post covid 19 syndrome
Antonello NICOLINI: please submit an approval letter of IRB Do not forget the lungs: I/E mode physiotherapy for people recovering from COVID-19. Preliminary feasibility
Do not forget the lungs: I/E mode physiotherapy for people recovering from COVID-19. Preliminary feasibility study
16039
evaluation of respiratory function parameters quality of life scores exercise capacity befora and after teatment with T-PEP 4 in patients with post COVID 19 syndrome
单臂
回顾性研究
na
/
no founding sources
/
20
/
2021-01-18
2021-07-01
/
1. Aged >=18 years 2. Discharged from hospital after a COVID19 pneumonia 3. In spontaneous breathing 4. Able to breathe keeping a mouthpiece 5. Mild to moderate obstructive syndrome at spirometry (12) and at least one symptom among: (1) Breathlessness or feeling as “I can't take a deep breath” or inability to yawn (2) Cough (3) Chest pain/Chest tightness (4) Dyspnoea (at rest or during normal ADL) (5) Oxygen desaturation >=4% during daily physical activities；
请登录查看Already on treatment with NIV or CPAP before COVID 19 - Oxygen supplementation at rest - Inability or refusal to collaborate - Lack of informed consent - Severe obstructive syndrome ( forced expiratory volume 1 second - FEV1 - < 50% )；
请登录查看asl4 chiavarese chiavari
/
标新生物GLUETACS2025-12-12
兽药资讯2025-12-12
医麦创新药2025-12-12
求实药社2025-12-12
卫材中国2025-12-12
药时空2025-12-12
Being科学2025-12-12
康华股份2025-12-12
康臣药业2025-12-12
汉康生技2025-12-12
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
